Yes 42 and lower toxicity.
But as usual biotech is always risky, it takes longer than expected (recruitment, etc.)... so I can understand why it's not priced in yet.
To me we're not too far from TLX's fair value which should be around $14 if you ask me, and $18 (as per USB) as soon as 250 is given FDA approval.
Ann: Telix 2023 Full Year Results and Investor Webcast/Call, page-121
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.23 |
Change
-1.080(5.32%) |
Mkt cap ! $6.441B | |||
| Open | High | Low | Value | Volume |
| $18.92 | $19.57 | $18.68 | $65.94M | 3.461M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 1004 | $19.23 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.24 | 972 | 13 |
View Market Depth
| Last trade - 12.40pm 24/07/2024 (20 minute delay) ? |
| TLX (ASX) Chart |